Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Urinary kallidinogenase for acute cerebral infarction with middle cerebral artery stenosis
ChiCTR-OPC-15006076Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Harbin Medical University
- Start
- Apr 2015
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of Human urinary kallidinogenase in brain infarction (2 arms), sponsored by The First Affiliated Hospital of Harbin Medical University. Primary endpoints: CTA-MIP collateral score, National Institutes of Health Stroke Scale and 3 more. Planned start Apr 2015; status: not yet recruiting.
02
Drugs
Human urinary kallidinogenase
03
Conditions
brain infarction
Beyond the preview
Go deeper on ChiCTR-OPC-15006076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-15006076.